Ivan Rosa-La
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.
Journal: Journal of internal medicine
Published: March 02, 2022
Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.
Journal: Frontiers in immunology
Published: July 20, 2021
Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.
Journal: Frontiers in immunology
Published: November 20, 2020
Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis.
Journal: Therapeutic advances in musculoskeletal disease
Published: June 29, 2020
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.
Journal: Therapeutic advances in chronic disease
Published: May 14, 2020
Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission.
Journal: Pediatric rheumatology online journal
Published: January 13, 2020
Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.
Journal: Autoimmunity reviews
Published: November 16, 2019
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS.
Journal: Rheumatology (Oxford, England)
Published: March 28, 2019
Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion.
Journal: Journal of cellular and molecular medicine
Published: February 21, 2019
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.
Journal: Autoimmunity reviews
Published: June 21, 2018
Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues.
Journal: Journal of internal medicine
Published: March 14, 2018
Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: June 30, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026